It has previously been reported that disease-associated prion protein (PrP d 
INTRODUCTION
The transmissible spongiform encephalopathies (TSEs) are a group of progressive neurological disorders that affect a number of animal species and humans and include scrapie of sheep and goats and bovine spongiform encephalopathy (BSE). A variant form of Creutzfeldt-Jakob disease (vCJD) of humans was initially described in 1996 and is thought to have been the result of BSE-infected cattle tissues entering the human food chain. The nature of the agent causing TSEs is still in dispute, but an abnormal isoform of a hostencoded cell-surface glycoprotein (prion protein, PrP c ) accumulates during disease and is associated closely with infectivity. This disease-associated form of PrP is insoluble and partially protease-resistant (PrP res ). Disease-associated PrP may also be revealed by immunohistochemical (IHC) methods that do not involve enzymic pre-treatment, therefore requiring the use of different terminology (PrP d ).
Since the ban on the use of ruminant feed in the 1990s, the prevalence of BSE in cattle in the UK has declined steadily and it has recently been suggested that the incidence of vCJD cases may have peaked in 2000 (Andrews et al., 2003) . However, sheep may also have been exposed to BSEcontaminated meat and bonemeal during the mid-1980s and mid-1990s (Butler, 1998) and previous studies have shown that BSE may be transmitted readily to sheep by oral, intravenous and intracerebral routes (Foster et al., 1993; Jeffrey et al., 2001c; Houston et al., 2003) . The possibility that consumption of BSE-infected sheep meat may pose a risk to humans has prompted urgent research into this area. As sheep originally exposed to cattle BSE would not be in production at present and as the feeding of meat and bonemeal to ruminants is no longer legal, any ovine BSE infection could only be maintained by transmission between sheep. Whilst maternal and horizontal (except from contaminated feedstuffs) methods of transmission of cattle BSE do not occur or are epidemiologically insignificant (Wilesmith et al., 1997) , scrapie is maintained endemically in flocks through sheep-to-sheep contagion. However, as the distribution of PrP d in tissues of sheep infected orally with BSE (Jeffrey et al., 2001c) resembles that of natural sheep scrapie more closely than that of cattle BSE (Van Keulen et al., 1996 , 2000 Jeffrey et al., 2001b; Heggebø et al., 2002) , the epidemiological features of BSE in cattle cannot be taken as an example for any potential naturally occurring sheep BSE.
Detectable infectivity in cattle with BSE is mainly confined to tissues that may be excised from the carcass, thus rendering the risk to man via the food chain low (Wells et al., 1998) . Evidence obtained from mouse bioassay has shown that, in experimental cattle BSE, infectivity is present in the distal ileum between 6 and 18 months post-infection, in the central nervous system (CNS) and dorsal root ganglia at 32 months post-infection and in the peripheral nervous system between 32 and 40 months post-infection (Wells et al., 1998) , with the earliest onset of clinical signs taking place at 35 months post-infection. This pattern is in marked contrast to BSE infection of sheep. By using IHC detection of PrP d as a marker (Prusiner, 1999) , infectivity has been found in the intestinal Peyer's patches as early as 5 months post-infection (Jeffrey et al., 2001c) . Subsequently, spread to the enteric nervous system and spinal cord occurs after 10 months and widespread dissemination throughout the lymphoreticular and peripheral nervous systems by 21 months post-infection (Jeffrey et al., 2001c) . This widespread infectivity of tissues in experimentally BSE-infected sheep (and also in natural scrapie) would make successful excision of high-risk tissues from the carcass impractical.
In previous studies, we have shown that oral BSE in sheep of the ARQ/ARQ genotype can be distinguished from natural sheep scrapie by differences in the immunolabelling patterns of phagocytic cells and neurons with a panel of PrP antibodies (Jeffrey et al., 2001a González et al., 2003) . The intracellular aggregates of PrP d in tingible body macrophages (TBMs) and in glial cells are located in lysosomes (Jeffrey et al., 1994 (Jeffrey et al., , 2000 , where they are acted upon by endogenous proteases, so that the full-length protein will be truncated and partially digested. The site of truncation within the N terminus of PrP appears to be different for sheep scrapie and experimental sheep BSE, giving rise to distinct IHC patterns. These data have recently been supported by Western blot studies on brain (Stack et al., 2002; Lezmi et al., 2004; Thuring et al., 2004) , which suggest that, after digestion by exogenous enzymes, the BSE PrP res molecule is shorter than that obtained from all sheep scrapie sources so far tested. Preliminary studies of the brains of three BSE-affected ARR/ARR sheep also showed similar features (Houston et al., 2003) .
In order to determine whether the truncation patterns of PrP d and/or PrP res reported previously in ARQ/ARQ sheep challenged orally with BSE are influenced by route of infection or by the genotype of the host, we have examined six groups of sheep with different PrP genotypes that had been challenged orally, intracerebrally (IC) or intravenously (IV) with BSE agent. In the present study, we show that the route of infection and the host PrP genotype do not affect the immunolabelling and Western blotting properties of sheep BSE PrP d .
METHODS
Animals and experimental details. Fifteen sheep of three different genotypes (ARQ/ARQ, VRQ/VRQ and ARR/ARR, n=5 in each) were infected experimentally by the IC route as described by Foster et al. (1993) . Briefly, 0?5 ml of a 10 % brainstem homogenate made from a pool of three confirmed cattle BSE cases was delivered at a point approximately 4 cm caudal to the frontal crest and 1 cm lateral to the midline at a depth of 2-3 cm via a 5 cm, 21 gauge needle. Thirteen of the IC-infected animals were of the Cheviot breed and two were Suffolk sheep (Table 1) . IV BSE infection was carried out in ten Cheviot sheep. Five of them (ARQ/AHQ PrP genotype) were challenged with 20 ml of a 1 % dilution of the same cattle-brain pool as was used for IC challenge. The other five (ARQ/ ARQ) were inoculated with 400-450 ml whole blood (or its buffy coat equivalent diluted in 50 ml PBS) obtained from three donor Cheviot sheep that had previously been exposed to BSE by the oral route (see below). The IV experiments have been described in detail by Hunter et al. (2002) . Three AHQ/AHQ Cheviot sheep were challenged by the oral route with a 10 % homogenate of a cattlebrain BSE pool, as described previously (Jeffrey et al., 2001c) .
Sheep genotypes were assigned following sequencing of the PrP gene coding region, as described by Baylis et al. (2000) , and are represented by single-letter codes at codons 136, 154 and 171, respectively. All of the 28 animals used in this study had developed clinical signs of TSE, with group mean incubation periods ranging from 565 to 1274 days (Table 1 ). For comparison with BSE, tissues obtained from naturally affected ARQ/ARQ Suffolk sheep from a heavily scrapie-infected flock (Jeffrey et al., 2001b) were subjected to the same laboratory examinations as experimental BSE cases.
Immunohistochemistry. After developing clinical signs of TSE, animals were euthanized and post-mortem examination was performed. Samples of medulla oblongata at the level of the obex, spleen, palatine tonsil and mesenteric lymph node (MsLN) were fixed in neutral 10 % phosphate-buffered formalin, trimmed, postfixed and embedded according to standard procedures. Sections (5 mm thick) were cut on a microtome, mounted on treated glass slides (Superfrost Plus; Menzel-Glaser) and dried overnight at 37 uC.
IHC methods have been described previously (González et al., 2002 (González et al., , 2005 . Briefly, tissue sections were immersed in 98 % formic acid for 15 min, followed by 30 min autoclaving at 121 uC in 0?2 % citrate buffer, pH 6?4. Incubation with the primary antibody was performed overnight at 4 uC and the rest of the IHC protocol was performed by a commercial immunoperoxidase technique (VECTASTAIN Elite ABC; Vector Laboratories), tissue sections being finally counterstained with Mayer's haematoxylin. Serial sections of each tissue sample were immunolabelled with five different PrP antibodies, namely R145 (rat mAb at 1/4000 dilution), P4 (mouse mAb at 1/20 000 dilution), 521 and 505 (rabbit polyclonal antisera at 1/10 000 and 1/6000 dilutions, respectively) and BG4 (mouse mAb at 1/2000 dilution). The PrP epitope affinity of these antibodies has been referred to previously (Jeffrey et al., 2001a González et al., 2003) . BG4 was raised against recombinant bovine PrP and mapped to a sequence between amino acids 45 and 57 by Pepscan analysis (Geysen et al., 1984) . The epitope recognized by the P4 antibody (amino acids 93-99 of ovine PrP) has recently been determined precisely (Thuring et al., 2004) .
Control tissues used in each IHC run were as follows. For brain, positive controls included samples of obex from a clinically sick sheep previously challenged with ovine BSE and from a Suffolk sheep naturally affected with scrapie. For lymphoid tissues, positive controls consisted of samples of tonsil or MsLN from an ARQ/ARQ sheep challenged orally with BSE and from an ARQ/ARQ Suffolk sheep with natural scrapie. As negative controls, samples of obex and LRS tissues from a normal, unaffected ARQ/ARQ sheep were used.
Morphometric methods and statistical analysis. Morphometric estimations of the amount of PrP d accumulation were performed for tonsil, MsLN and spleen on all sheep included in the study. To determine the distribution and intensity of PrP d accumulation in these tissues, two parameters were scored: the percentage of positive follicles and the magnitude and distribution of PrP d labelling within follicles. To avoid biases arising from variation in follicle size or in the site of PrP d accumulation, only follicles in which distinct light and dark zones could be seen were counted. The magnitude of labelling was scored as follows: 0, no labelling; 1, labelling confined to only one or two TBMs in the light zone; 2, TBM labelling throughout the light zone; 3, TBM labelling in both the light and dark zones; 4, TBM labelling in both the light and dark zones and weak labelling associated with follicular dendritic cells (FDCs) present in the light zone; 5, as for 4, but intense FDC-type labelling in the light zone. These labelling patterns are interpreted to indicate a progressive increase in the magnitude and/or duration of follicular infection. For each LRS tissue examined, a mean value was obtained from those follicles that actually showed PrP d immunolabelling.
Comparisons of morphometric data, both percentage of positive follicles and magnitude of immunolabelling, obtained from the different sheep groups examined were performed by Student's twosample test using a commercially available statistical package (InStat; Graphpad Software).
Western blotting. Western blotting was performed on samples of brain from all IC-challenged sheep in order to detect PrP res . PrP res was extracted by using modifications of the methods described by Hope et al. (1986 Hope et al. ( , 1988 as follows: 0?2 g brain tissue was homogenized in 2?0 ml 0?01 M sodium phosphate, pH 7?4, 10 % (w/v) N-lauryl sarcosinate containing 1 mM phenylmethylsulphonyl chloride and 1 mM N-ethyl maleimide. The suspension was centrifuged at 13 000 g for 20 min. After discarding the pellet, the supernatant was centrifuged at 215 000 g for 150 min at 10 uC. The supernatant was discarded and the pellet was resuspended in 0?6 ml deionized water and shaken at 37 uC for 30 min. The sample was then adjusted to a volume of 1?8 ml with deionized water and to an ionic concentration of 0?6 M potassium iodide, 6 mM sodium thiosulphate, 1 % (w/v) N-lauryl sarcosinate and 10 mM sodium phosphate, pH 8?5. The sample was then treated with 50 mg proteinase K (PK) ml 21 and incubated with agitation at 37 uC for 60 min. The PK-treated fraction was sedimented through a 2 ml cushion of 20 % sucrose, 0?6 M potassium iodide, 6 mM sodium thiosulphate, 1 % (w/v) N-lauryl sarcosinate and 10 mM sodium phosphate, pH 8?5, by centrifugation at 285 000 g for 90 min at 10 uC. The pellets were dissolved in 23?4 M formic acid and dried under vacuum. Peptide-N-glycosidase F (PNGase)-treated PrP res was prepared by using the method described by Collinge et al. (1996) .
Samples were run on 14 % Tris/glycine gels (Novex) and immunoblotted onto PVDF membranes. For detection of PrP res , two mAbs were used: 6H4 (Prionics, 2 mg ml 21 ) diluted 1 : 5000 and P4 (RBiopharm, 1 mg ml 21 ) diluted 1 : 2500. Visualization of the blots was performed with a chemiluminescent substrate and Lumi-Film (both from Roche).
RESULTS

PrP d distribution and magnitude of accumulation in LRS tissues
It is well-known that, in some TSEs, such as sporadic CJD or BSE, and even in some scrapie-affected sheep, accumulation of Fig. 1a ). In sheep of these two genotypes, the percentage of PrP dpositive follicles was lower in the MsLN than in the tonsil (P<0?01), whereas the spleen did not show differences from either of the other two LRS tissues in this respect (Table 2 ; Fig. 1a) .
When values for the magnitude of PrP d accumulation within positive follicles were compared, a similar genotyperelated effect was found. ARQ/ARQ sheep showed a greater, although not statistically significant, magnitude of follicular immunolabelling than VRQ/VRQ animals ( Table 2 ; Fig. 1b) . Accumulation of PrP d was found to be consistently less intense in the MsLN than in the spleen or tonsil (Fig. 1b) . Statistical analysis indicated significant differences in the intensity of follicular labelling between the MsLN and the spleen for ARQ/ARQ and VRQ/VRQ sheep, significant differences between the MsLN and the tonsil for both genotypes and no differences between tonsil and spleen for either of these genotypes.
Following IV or oral inoculation, sheep of all three PrP genotypes examined showed a consistent involvement of the palatine tonsil but, in agreement with data from ICchallenged sheep, the MsLN and spleen were only affected consistently in ARQ/ARQ sheep (Table 1) . Both groups of IV-challenged sheep had a greater intrafollicular intensity of immunolabelling in the spleen when compared with the other two LRS tissues examined and a greater percentage of follicles accumulating PrP d in spleen than in tonsil and/ or MsLN (Table 2) . Conversely, orally challenged sheep had a lower percentage of follicles accumulating PrP d and a lower intrafollicular intensity of immunolabelling in the spleen when compared with the other two LRS tissues (Table 2) . Similarly, IV-challenged sheep had a greater percentage of follicles accumulating PrP d and intrafollicular intensity of immunolabelling in the spleen when compared with orally challenged sheep ( Table 2 ).
PrP d immunolabelling with different antibodies (peptide mapping) in LRS and CNS tissues
In previous studies, we have shown that, unlike scrapie, the intracellular truncation site of ovine BSE PrP d is influenced by the tissue and cell types in which it accumulates, giving rise to distinct patterns of intracellular immunolabelling when different PrP antibodies are employed. By using this IHC strategy, also called epitope mapping, the inferred shortest fragment of intracellular PrP d is detected in TBMs, followed by glial cells and neurons . In contrast, in natural sheep scrapie, intracellular PrP d appears to be of the same length, regardless of the cell type in which it accumulates, and is always longer than any intracellular PrP d found in sheep BSE. In the present study, we aimed to determine whether the host PrP genotype or the route of infection could affect these IHC differential properties of ovine BSE and whether or not differentiation between ovine BSE and sheep scrapie would still be possible independently of such variables.
A summary of the intracellular labelling patterns for LRS tissues is shown in Table 3 and examples are shown in Fig. 2 . As described above (see Tables 1 and 2 ), PrP d did not accumulate in the LRS tissues of all sheep studied, but when it did, intense, multifocal, granular accumulations could be identified throughout the light and dark zones of secondary follicles. This pattern of labelling is associated with intracellular accumulation of PrP d within TBMs. When tissues were immunolabelled with the C-terminal PrP antibody R145, the TBM-associated PrP d pattern could be seen in all positive follicles and LRS tissues. However, when serial sections of these tissues and secondary follicles were incubated with PrP N-terminal antibodies (BG4, P4, 521 and 505), there was little or no discernible labelling of TBMs. This antibody-dependent differential immunolabelling was not affected by the route of challenge or the host PrP genotype. In contrast to BSE-challenged sheep, LRS tissues from Suffolk scrapie-affected sheep showed labelling of TBMs with all the antibodies used except BG4 (Table 3) .
A summary of the intracellular immunolabelling patterns in brain is shown in Table 3 . All BSE-affected sheep, regardless of their PrP genotype and route of infection, showed evidence of intracellular labelling with some antibodies, but not with others. Intraglial labelling was observed consistently with the R145 antibody as intense, granular deposits of PrP d in close proximity to the nuclei of glial cells. With the 505 antibody, a pattern of intraglial labelling similar to that of the R145 antibody was found, albeit with a lower intensity and less uniform distribution. With the 521 antibody, large granular foci adjacent to the nuclei of glial cells were not seen. However, in some sheep where intense neuropil PrP d accumulation was present, fine puncta were occasionally seen in close proximity to glial nuclei. With the P4 antibody, no granular or fine punctuate labelling was seen near glial-cell nuclei. Although there was some variation in overall magnitude, the described pattern of immunolabelling with the four antibodies tested for intraglial PrP d was the same in all BSE-infected sheep (Table 3 ). In contrast, Suffolk sheep with natural scrapie showed similar magnitudes of intraglial PrP d accumulation with all four antibodies tested. As in the LRS, the BG4 antibody did not label any intracellular accumulations of PrP d .
In all BSE-affected sheep, intraneuronal accumulation of PrP d was not observed with the P4 or BG4 antibodies, but was found with all three other antibodies tested (Table 3 ; Fig. 3 ). In contrast, Suffolk sheep with natural scrapie showed similar magnitudes of intraneuronal PrP d accumulation with antibodies R145, 505, 521 and P4. As described previously, the extreme N-terminal antibody BG4 did not label intracellular PrP accumulations in glia or in neurons.
IHC of negative-control tissues
With the PrP antibodies R145, 505, 521 and BG4, no immunolabelling was detected in normal brain or LRS tissue samples. P4 provided weak labelling of light zones of secondary follicles in LRS tissues and diffuse labelling of grey matter in brain. Occasional neurons throughout the brain showed strong cytoplasmic labelling. These patterns were considered to represent PrP c (data not shown).
Western blotting profiles of PrP res accumulation in sheep challenged IC with BSE
The IHC epitope-mapping results described above suggest intracellular truncation of PrP d in phagocytic and nonphagocytic cells occurring at different sites of the N terminus (Jeffrey et al., 1994 (Jeffrey et al., , 2000 , and is therefore likely to result from enzymic activity. Western blotting and most other rapid testing methods for diagnosis of TSEs in ruminants use PK to reveal the presence of PrP res in tissue samples. Preliminary results from Western blotting analysis of experimental sheep BSE and natural scrapie indicate that the site of truncation by this exogenous enzyme differs between these two infections, allowing its differential diagnosis (Stack et al., 2002) . In the present study, we have addressed whether or not these differential immunochemical properties of sheep scrapie and ovine BSE PrP res depend on the host PrP genotype.
Samples of BSE-affected sheep brains analysed by Western blotting using the mAb 6H4 gave strong PrP res bands in all experimental BSE sheep (Fig. 4a) . A range of intensities of labelling with 6H4 and some variation in the speed of migration of PrP res was observed, but these were probably related to protein-loading levels and not to differences in PrP genotype. The apparently lower molecular mass of the unglycosylated fragment of PrP res from sheep BSE samples compared with scrapie samples (Stack et al., 2002) was observed consistently (Fig. 4a) and could be demonstrated more clearly by removing the carbohydrate side chains following treatment of the samples with PNGase (Fig. 4b) . The main differential Western blot feature between sheep BSE and natural scrapie is the decreased signal found in blots labelled with mAb P4 (Stack et al., 2002) . Samples of BSE-affected sheep brains analysed by Western blotting using the mAb P4 showed no significant differences between sheep of different PrP genotypes, which could be distinguished readily from scrapie controls (Fig. 4c) , as they showed a much lower labelling intensity. As samples from each of the different sources, scrapie and BSE, were prepared and split into two identical preparations prior to loading onto gels and exposure times of the gels were the same, the differences in Western blotting profile were not attributed to differences in protein content.
DISCUSSION
The IHC and Western blotting findings in the present study of experimental BSE infection in sheep of several PrP genotypes challenged by three routes of inoculation are similar to results obtained in earlier studies, where BSE infection was confined to orally challenged ARQ/ARQ sheep (Jeffrey et al., 2001a Stack et al., 2002; Thuring et al., 2004) . We have shown that the 'in vivo' and 'in vitro' truncation site of sheep BSE PrP d and PrP res , as revealed by IHC and immunoblotting, respectively, is independent of PrP genotype, sheep breed or route of challenge and differs from that of abnormal PrP that accumulates during natural and experimental sheep scrapie, as reported previously (Jeffrey et al., 2001a González et al., 2003) . These results suggest that it may be possible to base European-wide surveillance for natural sheep BSE on the truncation patterns of abnormal PrP.
Genotype-associated variation in the distribution and magnitude (proportion of positive lymphoid follicles and intensity of immunolabelling) of PrP d accumulation in LRS tissues was observed in sheep infected with the BSE agent by the IC route. All of these parameters were greater in animals of the PrP ARQ/ARQ genotype than in VRQ/VRQ sheep. The most conspicuous genotype effect, however, was the absence of any LRS involvement in ARR/ARR sheep, which is in agreement with a previous report (Houston et al., 2003) . Although peripheral replication is probably irrelevant to incubation period following IC challenge, there appears to be a genotype-related inverse relationship between LRS involvement and incubation period. Thus, an increased length of incubation period corresponds to a lower frequency and magnitude of PrP d accumulation in LRS tissues (Fig. 5) . The incubation period of sheep TSEs is often taken as a measure of susceptibility, and a greater susceptibility of ARQ/ARQ sheep to BSE infection has also been suggested in previous IC or oral experiments, although VRQ homozygotes were not represented in either of these studies (Foster et al., 1993 (Foster et al., , 2001a The presence of abnormal forms of PrP, as determined either by IHC or by Western blotting, is generally taken as a surrogate for the presence of infectivity (Prusiner, 1999) . Previous reports on natural scrapie and ovine BSE induced experimentally by the oral route describe ubiquitous PrP d involvement of all LRS tissues (Foster et al., 2001b; Jeffrey et al., 2001c) , the earliest and most consistent detection corresponding to the mesenteric and/or retropharyngeal lymph nodes (Van Keulen et al., 1996 , 2000 Andréoletti et al., 2000; Jeffrey et al., 2001b) . In the present study, different patterns of the spread of infectivity could be inferred from the magnitude of PrP d accumulation in the three LRS tissues examined following inoculation by different routes. In contrast to orally inoculated sheep, which showed consistent PrP d accumulation in all MsLN and palatine-tonsil follicles, IC-inoculated sheep showed a greater percentage of positive follicles in the tonsil than in the MsLN, in both ARQ-and VRQ-homozygous sheep (Table 2 ; Figs 1 and 2). We suggest that the relative increase in the involvement of the tonsil in IC-challenged sheep is probably a consequence of the route of infection, so that, following IC inoculation, a higher level of infectivity is delivered to the pharynx via cerebrospinal fluid drainage following overspill of the inoculum, whilst most other LRS tissues would experience a decreased or delayed exposure to infection. Similar variation in tissue exposure to infection could be inferred in the IV-challenged groups. In contrast to other groups, IV-inoculated sheep had a greater involvement of the spleen than other LRS tissues, suggesting that the exposure of the spleen is greater than that of other LRS tissues following delivery of infection by this route.
In previous studies of sheep challenged orally with BSE, different intracellular antibody-labelling patterns of PrP d were found within brain when compared with LRS tissues . As ultrastructural studies suggest that intracellular PrP d aggregates are found within lysosomes (Jeffrey et al., 1994 (Jeffrey et al., , 2000 , the differences in antibody-labelling patterns probably relate to variation in the truncation site of different cellular sources of PrP d . This variation might be related to cell-driven differences in PrP d conformation, to cell-specific variation in the enzymic content or to other biochemical conditions within lysosomes. These same patterns of between-cell variation of truncation were found in the present study, with the putative shortest fragment of intracellular BSE PrP d being found in TBMs and the longest in neurons, with glia occupying an intermediate position. As these patterns were common to all PrP genotypes, the present study shows that, in ovine BSE, PrP d processing and the resultant variable fragment sizes of PrP d in different cell types are not due to any conformational changes in PrP derived from amino acid substitutions at codons 136, 154 and 171.
In conclusion, this study shows that the antibody-labelling patterns of intracellular PrP d are the same in sheep of different genotypes infected with BSE by different routes and can be differentiated readily from those of all natural sheep scrapie sources so far examined. Wide-scale testing for sheep BSE based on proteinase-digested PrP res fragment sizes may therefore be feasible. In addition, these findings provide support for earlier studies and further suggest that sheep homozygous for alanine at codon 136 and glutamine codon 171 are more susceptible to BSE-agent infection than are other sheep genotypes.
